共 50 条
[4]
Risk Detection in Practice - do we have to rethink?
[J].
DIABETES STOFFWECHSEL UND HERZ,
2021, 30 (01)
:22-24
[8]
Do we have enough evidence for approval of nadofaragene firadenovec?
[J].
MINERVA UROLOGY AND NEPHROLOGY,
2022, 74 (05)
:646-647